SMALL PEPTIDES FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND OTHER BETA-AMYLOID PROTEIN FIBRILLOGENESIS DISORDERS

A composition of matter that includes the peptide sequence Arg-Val-Ala-Val-Ile-Met-Gly-amide (Dp-068). A pharmaceutical composition that includes peptide Arg-Val-Ala-Val-Ile-Met-Gly-amide (Dp-068). Use of the peptide for preparation of a medicament for the treatment of a diseases characterized by A²...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: BETH P. NGUYEN, GERARDO M. CASTILLO, THOMAS P. LAKE, VIRGINIA J. SANDERS, ALAN D. SNOW
Format: Patent
Sprache:eng ; por
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:A composition of matter that includes the peptide sequence Arg-Val-Ala-Val-Ile-Met-Gly-amide (Dp-068). A pharmaceutical composition that includes peptide Arg-Val-Ala-Val-Ile-Met-Gly-amide (Dp-068). Use of the peptide for preparation of a medicament for the treatment of a diseases characterized by A² fibrillogenesis. Use of an aantibody directed against a peptide comprising Arg-Val-Ala-Val-Ile-Met-Gly-amide in the manufacture of a medicament for the treatment of a disease characterized by A² fibrillogenesis. Preferably where at least one amino acid of the peptide sequence is a D-amino acid.